PLA2R related primary membranous nephropathy in a hepatitis C positive patient

Nephrology (Carlton). 2018 Mar;23(3):288. doi: 10.1111/nep.13044.

Authors

Raja Ramachandran¹, Ashok Kumar Yadav¹, Vinod Kumar¹, Ashwani Varma², Sunil Taneja³, Ritambhra Nada², Krishan Lal Gupta¹, Vivekanand Jha^{4

5}

Affiliations

¹ Department of Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
² Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
³ Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
⁴ Department of Nephrology, Oxford University, Oxford, UK.
⁵ The George Institute for Global Health, New Delhi, India.

PMID: 29460999
DOI: 10.1111/nep.13044

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antiviral Agents / therapeutic use
Autoantibodies / blood
Autoantibodies / immunology*
Biomarkers / blood
Female
Glomerulonephritis, Membranous / diagnosis
Glomerulonephritis, Membranous / drug therapy
Glomerulonephritis, Membranous / immunology
Glomerulonephritis, Membranous / virology*
Hepacivirus / drug effects
Hepacivirus / immunology
Hepacivirus / pathogenicity*
Hepatitis C / diagnosis
Hepatitis C / drug therapy
Hepatitis C / immunology
Hepatitis C / virology*
Host-Pathogen Interactions
Humans
Immunosuppressive Agents / therapeutic use
Middle Aged
Receptors, Phospholipase A2 / immunology*
Treatment Outcome
Viral Load

Substances

Antiviral Agents
Autoantibodies
Biomarkers
Immunosuppressive Agents
PLA2R1 protein, human
Receptors, Phospholipase A2